Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia

Journal of Affective Disorders

Volumn 124, Issue 1-2, 2010, Pages 164-169

  Yuan, Peixiong ^a   Zhou, Rulun ^a   Wang, Yun ^a   Li, Xiaoxia ^a,b   Li, Jianling ^a   Chen, Guang ^a   Guitart, Xavier ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Bipolar disorder; Brain; cAMP response binding element (CREB); Major depressive disorder; Protein regulation; Schizophrenia

Indexed keywords

B RAF KINASE; BETA ACTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NEURON SPECIFIC ENOLASE; RAP1 PROTEIN; S6 KINASE;

ADULT; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; SCHIZOPHRENIA; WESTERN BLOTTING;

ACTINS; ADULT; BIPOLAR DISORDER; BLOTTING, WESTERN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSIVE DISORDER, MAJOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FRONTAL LOBE; HUMANS; MALE; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONAL PLASTICITY; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS B-RAF; REFERENCE VALUES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SCHIZOPHRENIA; TELOMERE-BINDING PROTEINS;

EID: 77952287347     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.10.017     Document Type: Article

References (35)

1. Bachmann R.F., Schloesser R.J., Gould T.D., and Manji H.K. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol. Neurobiol. 32 (2005) 173-202
2. Cahn W., Rais M., Stigter F.P., van Haren N.E., Caspers E., Hulshoff Pol H.E., Xu Z., Schnack H.G., and Kahn R.S. Psychosis and brain volume changes during the first five years of schizophrenia. Eur. Neuropsychophamacol. 19 (2009) 147-151
3. Cestari V., Costanzi M., Castellano C., and Rossi-Arnaud C. A role for ERK2 in reconsolidation of fear memories in mice. Neurobiol. Learn. Mem. 86 (2006) 133-143
4. Chen G., and Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr. Opin. Psychiatry 19 (2006) 313-323
5. Chen G., Creson T., Sharon E., Hao Y., and Wang G. Neurotrophic actions of mood-stabilizers: a recent research discovery and its potential clinical applications. Curr. Psychiatry Rev. 2 (2005) 173-185
6. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann. N.Y. Acad. Sci. 1053 (2005) 195-204
7. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
8. Creson T.K., Yuan P., Manji H.K., and Chen G. Evidence for involvement of ERK, PI3K, and RISK in induction of Bcl-2 by valproate. J. Mol. Neurosci. 37 (2009) 123-134
9. Dowlatshahi D., Wang J.F., MacQueen G., and Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352 (1998) 1754-1755
10. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., and Young L.T. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J. Neurochem. 73 (1999) 1121-1126
11. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
12. Duman R.S. Windows of the human brain and the neurobiology of psychiatric disorders. Neuropsychopharmacology 26 (2003) 141-142
13. Dwivedi Y., Rizavi H.S., Conley R.R., and Pandey G.N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol. Psychiatry 11 (2006) 86-98
14. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23 (2003) 7311-7316
15. Fu Z., Lee S.H., Simonetta A., Hansen J., Sheng M., and Pak D.T. Differential roles of Rap1 and Rap2 small GTPases in neurite retraction and synapse elimination in hippocampal spiny neurons. J. Neurochem. 100 (2007) 118-131
16. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 23 (2004) 6590-6599
17. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W.J., McDonald B., and Pearson R.C.A. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Let. 200 (1995) 151-154
18. Jarskog L.F., Gilmore J.H., Selinger E.S., and Lieberman J.A. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry 48 (2000) 641-650
19. Jordan B.A., Fernholz B.D., Boussac M., Xu C., Grigorean G., Ziff E.B., and Neubert T.A. Identification and verification of novel rodent postsynaptic density proteins. Mol. Cell. Proteomics 3 (2004) 857-871
20. Kim M.J., Dunah A.W., Wang Y.T., and Sheng M. Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46 (2005) 745-760
21. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 (2000) 289-305
22. Li J., Gould T.D., Yuan P., Manji H.K., and Chen G. Post-mortem Interval effects on the phosphorylation of signaling proteins. Neuropsychophamacology 28 (2003) 1017-1025
23. Lipska B.K., Deep-Soboslay A., Weickert C.S., Hyde T.M., Martin C.E., Herman M.M., and Kleinman J.E. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol. Psychiatry 60 (2006) 650-658
24. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welz H., Wolfer D.P., Pages G., Valverde O., Marowsky A., Porrazzo A., Orban P.C., Maldonado R., Ehrengruber M.U., Cestari V., Lipp H.P., Chapman P.F., Pouyssegur J., and Barmbilla R. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34 (2002) 807-820
25. Miguel-Hidalgo J.J., and Rajkowska G. Morphological brain changes in depression: can antidepressants reverse them?. CNS Drugs 16 (2002) 361-372
26. Morozov A., Muzzio I.A., Bourtchouladze R., Van-Strien N., Lapidus K., Yin D., Winder D.G., Adams J.P., Sweatt J.D., and Kandel E.R. Rap1 couples cAMP signaling to a distinct pool of p42/44MAPK regulating excitability, synaptic plasticity, learning, and memory. Neuron 39 (2003) 309-325
27. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
28. Sanacora G., Zarate C.A., Krystal J.H., and Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 7 (2008) 426-437
29. Shaltiel G., Chen G., and Manji H.K. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr. Opin. Pharmacol. 7 (2007) 22-26
30. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14 (2004) 311-317
31. Thomas G.M., and Huganir R.L. MAPK cascade signaling and synaptic plasticity. Nat. Rev., Neurosci. 5 (2004) 173-183
32. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
33. van Haren N.E., Barker S.C., and Kahn R.S. Genes and structural brain imaging in schizophrenia. Curr. Opin. Psychiatry 21 (2008) 161-167
34. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., and Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276 (2001) 31674-31683
35. Zhu J.J., Qin Y., Zhao M., Van Aelst L., and Malinow R. Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110 (2002) 443-455